Automated Autoinjectors Market Size, Share, Growth Analysis, 2032

Automated Autoinjectors Market: Industry Perspective

The global automated autoinjectors market size was worth around USD 3.76 billion in 2023 and is predicted to grow to around USD 6.74 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.70% between 2024 and 2032.

The report analyzes the global automated autoinjectors market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the automated autoinjectors industry.

Request Free Sample

Automated Autoinjectors Market: Overview

Automated autoinjectors are needle-based medical devices used for the administration of fixed dose for specific drug doses. It is used for self-administration by untrained personnel or patients, as it is easy to handle. Furthermore, these devices are used for various allergic reactions, such as wheezing, trouble in breathing, stomach pain, nausea, dizziness, swelling on face, lips, mouth, and tongue and skin allergies, like hives, itching, flushing, etc. Furthermore, the administration site depends on the nature of the drug. For example, insulin shots are injected in the abdomen for quick action. Automated autoinjectors are easy to use and have various advantages, such as reduced needle phobia anxiety, lowered chances of needlestick injuries, better efficacy, and consistent dose accuracy, which, in turn, are likely to propel the automated autoinjectors market globally in the future.

The rising incidences of anaphylactic shock, growing patient alertness about the effective use of automated autoinjectors, and increasing preference for automated autoinjectors for self-administration are likely to be the key growth drivers of the global automated autoinjectors market in the future. Government’s support to allow the marketing of these instruments in various locations is anticipated to further fuel the automated autoinjectors market globally in the years ahead.

As per the Allergy, Asthma and Clinical Immunology, around 15 million people suffered from food allergies in the UK in 2015, of which approximately 3.8 million were children. This data was backed by the WHO as well. This, in turn, signifies the rising prevalence of allergies globally. However, new drug delivery systems and new formulations combined with innovation in the biologic drug segment may impede the growth of the automated autoinjectors market globally.

In order to give the users of this report a comprehensive view of the automated autoinjectors market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market.

Request Free Sample

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

Automated Autoinjectors Market: Segmentation

The automated autoinjectors market is divided on the basis of design, application, usage, and end-user.

By design, the automated autoinjectors market is includes customized autoinjector and standardized autoinjector.

By usage, the market is segmented into reusable autoinjector and disposable autoinjector.

The application segment includes anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others.

By end-user, the market is segmented into hospitals and clinics and home care settings.

Automated Autoinjectors Market: Report Scope

Automated Autoinjectors Market: Regional Analysis

By region, North America dominated the global automated autoinjectors market in 2023. Presence of several leading players and favorable reimbursement scenario are major factors likely to propel the North American automated autoinjectors market in the future. The Asia Pacific automated autoinjectors market is projected to witness rapid growth in the next few years, owing to the rising awareness among consumers regarding the advanced treatment methods that are available. Lucrative growth opportunities in Japan, India, and China and technological advancements, increased healthcare expenditure, mandatory healthcare insurance, and the rising number of global companies catering to the unmet medical needs of the regional population are likely to further propel the automated autoinjectors market growth in this region.

Automated Autoinjectors Market: Competitive Analysis

The global automated autoinjectors market is dominated by players like:

• Unilife Corporation
• Becton, Dickinson & Co.
• Biogen Idec
• Pfizer, Inc.
• Mylan N.V.
• Sanofi
• Owen Mumford
• Teva Pharmaceutical
• Amgen
• Ypsomed
• AbbVie
• Scandinavian Health Ltd.

This report segments the global automated autoinjectors market into:

By Design Segment Analysis

• Customized Autoinjector
• Standardized Autoinjector

By Usage Segment Analysis

• Reusable Autoinjector
• Disposable Autoinjector

By Application Segment Analysis

• Anaphylaxis
• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Others

By End-User Segment Analysis

• Hospitals and Clinics
• Home Care Settings

By Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa